Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jyoti Sehjal
Observed name:
J. Sehjal
Institution:
University of Oxford
Observed institutions:
University of Oxford,
London School of Hygiene & Tropical Medicine
ORCID:
0000-0003-0083-6492
Observed ORCID:
0000-0003-0083-6492
OpenAlex ID:
A5018845464
Works
5
Awards
1
Clinical prediction models using machine learning in oncology: challenges and recommendations
2025
·
Gary S Collins
, Mae Chester-Jones
, et al.
·
BMJ Oncology
·
55
PDF
Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer—Randomised comparison from the STAMPEDE trial platform.
2025
·
Nicholas David James
, Hannah Rush
, et al.
·
Journal of Clinical Oncology
·
6
PDF
Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
2022
·
Jyoti Sehjal
, Linda D. Sharples
, et al.
·
Transplantation
·
1
Development of prognostic models in myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML): a systematic review and critical appraisal
2026
·
Jyoti Sehjal
, Paula Dhiman
, et al.
·
OSF Preprints (OSF Preprints)
A0474 – Androgen suppression, PSA response, toxicity and longer-term outcomes with transdermal oestradiol (tE2) patches compared with LHRH analogues for the treatment of locally advanced prostate cancer, the phase III PATCH (NCT00303784) and STAMPEDE (NCT00268476) trials
2025
·
D.C. Gilbert
, M. Nankivell
, et al.
·
European Urology
Show more works
View as search
Works count:
5
Citation count:
62
H-index:
2
I10-index:
1
Year
Topic
Type